A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Subscribe to our newsletter for the latest sci-tech news ...
A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Devon Tyso, a Product Design and Technology student, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results